GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
DCW Ltd
DCW Ltd held 16th Annual Investor/Analyst Conference on 23 March 2026
BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 24 Mar 2026, 10:56 AM IST  ·  BSE ID: 046b9db6-3e31-4062-bd13-2f98f8573318
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's management team attended an industry analyst conference in Mumbai to discuss business with investors and financial analysts.
🤖 AI Summary
  • DCW Ltd management attended 16th Annual Valoreum Pharma Group Analyst Conference on 23 March 2026
  • Conference held physically at Hyatt Mumbai, mode of venue explicitly specified
  • Meeting occurred at 9:00 AM, organised by Valoreum Pharma Group
  • Non-public sensitive information was shared and discussed during the conference
👥 What This Means For Shareholders
✅
Action Required
No action required.
👤
Who Is Affected
All shareholders are notified of management's investor conference participation under disclosure norms. No differential impact by shareholding class.
🔍
Management Signal
Management is actively engaged in investor relations and analyst outreach through structured conference participation.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Track analyst notes and research updates from Valoreum Pharma Group conference proceedings
Monitor next quarterly financial results for any guidance updates from conference
Check for follow-up material disclosures if conference sparked material agreements
LOW RISK Investor conference is standard practice. Non-public information sharing is controlled and compliant with disclosure rules.
💡 Investor Takeaway
DCW Ltd management attended the 16th Annual Valoreum Pharma Group Analyst Conference on 23 March 2026 in Mumbai. Non-public sensitive information was shared. Filing discloses routine investor relations activity with no material business or financial metrics.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.